ABSTRACT
INTRODUCTION
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disorder with high morbidity and mortality. SLE characterized by chronic inflammation, abnormal immune system response with failure of immunoregulatory mechanisms
(1) . SLE affects predominantly women of child-bearing age with multi-organ involvement and is characterized by variable clinical features, including glomerulonephritis, arthritis, and neuropsychiatric disease (2) . Kidney is one of the most commonly affected organs and lupus nephritis (LN) represents one of the most serious manifestations of SLE contributes to high mortality (3) . Increased oxidative stress contributes to the pathogenesis of some diseases as chronic kidney disease and autoimmune diseases (4) . Advanced oxidation protein products (AOPPs) are dityrosine-containing cross-linking proteins, formed by the reaction between chlorinated oxidants and proteins and derived from oxidation-modified albumin, fibrinogen, and lipoproteins. AOPPs have a role in induction of macrophage activation and apoptosis (5) . Patients with SLE demonstrate defective clearance of apoptotic cells which allows deposition of immune complexes that can stimulate B and T cells, causing tissue damage (6) . Nuclear factor kappa B (NF-κB), is a heterodimeric complex composed of two subunits termed p50 and p65 and is a key transcription factor involved in the regulation of immune responses and apoptosis (7, 8) . Calciphylaxis and calcinosis are soft-tissue calcification associated with SLE morbidity and mortality (9) . Fetuin-A (α 2 -Heremans-Schmid glycoprotein AHSG) is glycoprotein predominantly synthesized in liver (10) . It is generally recognized as a calcification inhibitor rather than negative inflammatory marker, which facilitates the formation of soluble calciprotein particles and limits the formation of hydroxyapatite crystals (10) . 25-hydroxivitamin D (25OHD) is one of sterols with a critical role in calcium, phosphorus metabolism, although vitamin D is consumed in food, dietary intake alone is often insufficient, supplying only 20% of the body's requirements (11) . The main source of vitamin D is the conversion of 7-dehydrocholesterol to previtamin D 3 in the skin, by means of solar ultraviolet B (UVB) radiation. The fully active form, calcitriol (1,25(OH)2D), is synthesized in the kidneys (12) . Vitamin D deficiency has a role in the development of neoplasm, cardiovascular disease, increased susceptibility to infections and autoimmune diseases. 25OHD is an immunomodulatory hormone through its inhibitory effect on T lymphocytes, B lymphocytes and dendrite cells as well as it can alter the cytokine production profile (13) . The aim of the current study is to evaluate the relationship between AOPPs, NF-κB, fetuin-A and 25OHD level as well as calculated calcification risk index (CRI) and LN, and to evaluate their possible clinical significance in disease activity and progression.
PATIENTS & METHODS

Patients:
The All individuals of the study were subjected to full history taking, thorough clinical examination and those with a history of diabetes mellitus, coronary artery disease (CAD), malignancy, concurrent infection, other connective tissue disorders such as rheumatoid arthritis, liver or other kidney diseases and oral prednisolone greater than 10 mg/day were excluded from the study.
Sample preparation:
Overnight fasting venous blood samples were aseptically collected. Part was collected in plane tubes, centrifuged and the recovered serum aliquots were stored at -80⁰C for analysis of fetuin-A and 25OHD levels. For PBMCs NF-κB level and plasma AOPPs levels, another part of the blood sample was collected on plastic tubes containing K 2 EDTA at a final concentration of 1.2 mg EDTA/ml and was used for plasma and PBMCs separation. Blood was added slowly along the sides of the tube containing Ficoll hypaque (Sigma Aldrich) and centrifuged at 400 x g for 20 minutes. PBMCs (white interphase layer), plasma (upper layer) Table ( 2) and figure (1) (a,b,c,d and e) show comparative statistics of different biochemical studied parameters among all studied groups. There were statistically significant differences in values of plasma AOPPs (μmol/L), PBMCs NF-κB level (ng/ml) and CRI among all studied groups (F values were 10.36, 9.634, and 11.61 respectively, P < 0.05). Using multiple comparisons test (Tukey's test), the values were markedly higher in group III and group II when compared to group I with statistically higher values in group III. There were statistically significant lower levels of serum fetuin-A (pg/ml), and 25OHD (ng/ml) between group III and group II with statistically lower level in group III.
RESULTS
Also, there were statistically insignificant differences in values of serum Ca (mg/dl) and serum inorganic phosphate (mg/dl) between all studied groups, by using multiple comparisons test (Tukey's test), there were statistically significant differences between group I and III and between group II and III with statistically significant lower serum Ca and higher inorganic phosphate levels in group III than group I and group II. The significant differences in levels of previous parameters reflect their strong relation to LN disease activity and progression. Table ( 3) shows person correlation between PBMCs NF-κB (ng/ml) plasma AOPPs μmol/L levels and CRI with serum levels of 25OHD (ng/ml) and fetuin-A (pg/ml) in patient groups (group II and III), negative correlations were found between PBMCs NF-κB (ng/ml), plasma AOPPs (μmol/L) levels and CRI with serum levels of both 25OHD (ng/ml) and fetuin-A (pg/ml) in patient groups (r value was -0.362, -0.425, -0.419, -0.377, -0.296 and -0.536 respectively, P < 0.05). AOPPs μmol/L CRI, serum 25OHD level (ng/ml) and serum fetuin-A level (pg/ml) with some laboratory parameters in patient groups. Statistically significant positive correlation were found between PBMCs NF-κB level (ng/ml), plasma AOPPs (μmol/L), CRI and serum creatinine (mg/dl), 24 hours urinary albumin (mg/24 hours), ESR-1 (mm/hour), CRP (mg/L), ANA (IU/ml), Anti-dsDNA antibodies (IU/ml), SLEDAI score. Meanwhile, serum levels of 25OHD (ng/ml), fetuin-A (pg/ml) showed statistically significant negative correlation with the above studied parameters. These results reflect the relationship of studied parameters to LN disease activity and progression. . This result may be explained by photosensitivity, renal involvement with defect in 1-Hydroxylation which is essential to make the active form of vitamin D and hydroxychloroquine used in SLE treatment which can lower the conversion of provitamin D 3 to the active vitamin D 3 , also elevated inorganic phosphate level inhibits 25OHD conversion to 1,25(OH)2D
(51) . The reduction in 1,25(OH)2D decreases intestinal absorption of Ca that causes hypocalcemia. Hyperphosphatemia leads to the development of renal bone disease, extraosseous calcifications of soft tissue and vasculature. Also, inorganic phosphate level more than 6.5 mg/dl and higher CRI is associated with increased risk of death (52) . This current study revealed positive correlation between PBMCs NF-κB level , AOPPs level and CRI with levels of creatinine, 24-hours urinary protein, ANA, anti-dsDNA antibodies, CRP, ESR-1 and SLEDAI, on the other hand an inverse correlation was detected with serum fetuin-A and 25OHD in SLE patient groups included in the present work. On the basis of these observations, it could be suggested that the decrease in the serum levels of fetuin-A and 25OHD and the increase in the levels of PBMCs NF-κB and plasma AOPPs`s as well as CRI occur during the course of the disease activity and progression. 
CONCLUSION
